ASX BRIEFS

BRAZILIAN CRITICAL MINERALS LTD (BCM) - BCM’s Ema Project Explained From Giant Clay Resource To Low Cost In Situ Recovery

• Andrew Musgrave

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 10:39

Send us Fan Mail

A rare earth project that aims to get to production without crushers, grinding circuits, or a high-cost processing maze gets our attention fast. We sit down again with Andrew Reid, Managing Director of Brazilian Critical Minerals (ASX: BCM), to unpack the Ema ionic adsorption clay deposit in Brazil and why in situ recovery (ISR) could be a genuine cost and schedule advantage for a new Western rare earth supply source.

We walk through the latest drilling at Ema and what it says about scale and consistency, alongside the updated mineral resource estimate that underpins the move toward a bankable feasibility study (BFS). Andrew explains the vertical profile many clay deposits show, including enrichment toward the base of the clay, and why Ema’s rare earth mix stands out. We also dig into the commercial reality of rare earths: buyers care about the basket, so discussions around neodymium praseodymium and the presence of heavies like dysprosium and terbium can shape offtake interest and downstream pathways.

From there, we get practical on execution risk. Andrew shares where the BFS work is focused now, why BCM is doing capital cost estimation in-country in Brazil, and how sourcing standard equipment locally can support credibility. We also cover BCM’s collaboration agreement with an established ISR operator and the strategic tailwinds Andrew is seeing in US-facing conversations about critical minerals and rare earth supply chain security.

If you’re tracking ASX rare earth stocks, Brazilian critical minerals, or the path from feasibility to financing, this is a grounded look at what matters next: BFS completion, permitting, offtake, and bankable project funding. Subscribe, share the episode with a mate who follows rare earths, and leave a review with the key risk or catalyst you think will decide the outcome.